Key Characteristics of Human Hepatotoxicants as a Basis for Identification and Characterization of the Causes of Liver Toxicity

Hazard identification regarding adverse effects on the liver is a critical step in safety evaluations of drugs and other chemicals. Current testing paradigms for hepatotoxicity rely heavily on preclinical studies in animals and human data (epidemiology and clinical trials). Mechanistic understanding of the molecular and cellular pathways that may cause or exacerbate hepatotoxicity is well advanced and holds promise for identification of hepatotoxicants. One of the challenges in translating mechanistic evidence into robust decisions about potential hepatotoxicity is the lack of a systematic approach to integrate these data to help identify liver toxicity hazards. Recently, marked improvements were achieved in the practice of hazard identification of carcinogens, female and male reproductive toxicants, and endocrine disrupting chemicals using the key characteristics approach. Here, we describe the methods by which key characteristics of human hepatotoxicants were identified and provide examples for how they could be used to systematically identify, organize, and use mechanistic data when identifying hepatotoxicants.

[1]  C. Bocca,et al.  Liver fibrogenesis: UN update on established and emerging basic concepts. , 2020, Archives of biochemistry and biophysics.

[2]  Sijin Liu,et al.  TCDD promotes liver fibrosis through disordering systemic and hepatic iron homeostasis. , 2020, Journal of hazardous materials.

[3]  Z. Younossi,et al.  Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD , 2020, Hepatology.

[4]  J. Little,et al.  Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans , 2019, Journal of toxicology and environmental health. Part B, Critical reviews.

[5]  N. Kang Mechanotransduction in Liver Diseases , 2019, Seminars in Liver Disease.

[6]  R. Schwabe,et al.  Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice. , 2019, Gastroenterology.

[7]  R. Prough,et al.  Mechanisms of Environmental Contributions to Fatty Liver Disease , 2019, Current Environmental Health Reports.

[8]  P. Kamath,et al.  Burden of liver diseases in the world. , 2019, Journal of hepatology.

[9]  R. Yang,et al.  DAMPs and sterile inflammation in drug hepatotoxicity , 2018, Hepatology International.

[10]  T. Luedde,et al.  Apoptosis and necroptosis in the liver: a matter of life and death , 2018, Nature Reviews Gastroenterology & Hepatology.

[11]  N. Kaplowitz,et al.  New insights into the role and mechanism of c‐Jun‐N‐terminal kinase signaling in the pathobiology of liver diseases , 2018, Hepatology.

[12]  Ivan Rusyn,et al.  Application of the key characteristics of carcinogens in cancer hazard identification , 2018, Carcinogenesis.

[13]  M. Fielden,et al.  Modernizing Human Cancer Risk Assessment of Therapeutics. , 2017, Trends in pharmacological sciences.

[14]  T. Monticello,et al.  Current nonclinical testing paradigm enables safe entry to First‐In‐Human clinical trials: The IQ consortium nonclinical to clinical translational database , 2017, Toxicology and applied pharmacology.

[15]  G. Kullak-Ublick,et al.  Drug-induced bile duct injury. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[16]  N. Kaplowitz,et al.  Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis , 2017, International journal of molecular sciences.

[17]  Jiezhun Gu,et al.  Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements , 2017, Hepatology.

[18]  E. Bjornsson Drug-induced liver injury due to antibiotics , 2017 .

[19]  B. K. Park,et al.  Amoxicillin and Clavulanate Form Chemically and Immunologically Distinct Multiple Haptenic Structures in Patients. , 2016, Chemical research in toxicology.

[20]  Marlene Ågerstrand,et al.  Implementing systematic review techniques in chemical risk assessment: Challenges, opportunities and recommendations. , 2016, Environment international.

[21]  Ivan Rusyn,et al.  Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis , 2015, Environmental health perspectives.

[22]  C. McClain,et al.  Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences , 2015, Cellular and molecular gastroenterology and hepatology.

[23]  T. Luedde,et al.  Cell death and cell death responses in liver disease: mechanisms and clinical relevance. , 2014, Gastroenterology.

[24]  D. Tweedie,et al.  The Role of Transporters in Toxicity and Disease , 2014, Drug Metabolism and Disposition.

[25]  Mitchell R. McGill,et al.  Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans. , 2014, Toxicology and applied pharmacology.

[26]  T. Starr,et al.  Mode of action and dose–response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study , 2014, Critical reviews in toxicology.

[27]  G. Gores,et al.  Apoptosis and necrosis in the liver. , 2013, Comprehensive Physiology.

[28]  K.,et al.  Toxicant-associated Steatohepatitis , 2013, Toxicologic pathology.

[29]  Michael Karin,et al.  A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. , 2012, Gastroenterology.

[30]  J. Manautou,et al.  Molecular mechanisms underlying chemical liver injury , 2012, Expert Reviews in Molecular Medicine.

[31]  Mitchell R. McGill,et al.  Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity , 2012, Drug metabolism reviews.

[32]  J. Boyer,et al.  Drug‐induced cholestasis , 2011, Hepatology.

[33]  B. Fromenty,et al.  Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. , 2011, Journal of hepatology.

[34]  J. Ward,et al.  Hepatic Enzyme Induction , 2010, Toxicologic pathology.

[35]  D. Adams,et al.  Mechanisms of immune-mediated liver injury. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  J. Ross,et al.  Liver Development, Regeneration, and Carcinogenesis , 2010, Journal of biomedicine & biotechnology.

[37]  K. Zatloukal,et al.  The role of the hepatocyte cytokeratin network in bile formation and resistance to bile acid challenge and cholestasis in mice , 2009, Hepatology.

[38]  Ivan Rusyn,et al.  Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[39]  N. Kaplowitz,et al.  ER stress: can the liver cope? , 2006, Journal of hepatology.

[40]  N. Kaplowitz,et al.  Hepatic mitochondrial glutathione: transport and role in disease and toxicity. , 2005, Toxicology and applied pharmacology.

[41]  Terry S Peters,et al.  Do Preclinical Testing Strategies Help Predict Human Hepatotoxic Potentials? , 2005, Toxicologic pathology.

[42]  Martyn T. Smith,et al.  Mechanisms of troglitazone hepatotoxicity. , 2003, Chemical research in toxicology.

[43]  G. Gores,et al.  Mechanisms of hepatotoxicity. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[44]  G. Orphanides,et al.  Role of cytokines in non-genotoxic hepatocarcinogenesis: cause or effect? , 2001, Toxicology letters.

[45]  Cody L. Wilson,et al.  Mechanisms of Ligand-Induced Aryl Hydrocarbon Receptor-Mediated Biochemical and Toxic Responses , 1998, Toxicologic pathology.

[46]  Steven D. Cohen,et al.  Selective protein covalent binding and target organ toxicity. , 1997, Toxicology and applied pharmacology.

[47]  D. Parke Mechanisms and consequences of the induction of microsomal enzymes of mammalian liver. , 1972, The Biochemical journal.

[48]  Ellen Mantus,et al.  Using 21st Century Science to Improve Risk-Related Evaluations , 2017 .

[49]  Ivan Rusyn,et al.  In vitro models for liver toxicity testing. , 2013, Toxicology research.

[50]  G. Gores,et al.  Liver cell necrosis: cellular mechanisms and clinical implications. , 1995, Gastroenterology.